Valuation: C-Rad AB

Market Cap 794M 81.09M 72.4M 66.44M 60.43M 113M 7.68B 116M 320M 4.05B 304M 298M 12.8B P/E 2026 *
13.9x
P/E 2027 * 12x
Enterprise Value 636M 64.96M 57.99M 53.22M 48.41M 90.76M 6.15B 92.57M 256M 3.25B 244M 239M 10.25B EV / Sales 2026 *
1.54x
EV / Sales 2027 * 1.3x
Free-Float
50.36%
Yield 2026 *
1.91%
Yield 2027 * 2.34%
1 day-0.64%
1 week+9.43%
1 month-31.76%
3 months-34.83%
6 months-10.08%
Current year-27.39%
1 week 21.1
Extreme 21.1
24.4
1 month 18.85
Extreme 18.85
34
Current year 18.85
Extreme 18.85
39.4
1 year 18.85
Extreme 18.85
39.4
3 years 18.85
Extreme 18.85
49.95
5 years 18.85
Extreme 18.85
56.1
10 years 9.85
Extreme 9.85
67.4
Manager TitleAgeSince
Chief Executive Officer 56 2026-02-01
Chief Executive Officer 49 2025-10-20
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 52 2016-12-31
Director/Board Member 60 2021-05-06
Chairman 61 2023-05-04
Date Insider Type Main position Quantity % Market Cap. Importance
8/11/26 Buy

Chief Financial Officer

2,000 0.0061%
8/10/26 Sell

Chief Financial Officer

-2,000 0.0061%
7/31/26 Buy

Chief Financial Officer

2,000 0.0061%
Change 5-day change 1-year change 3-year change Capi.($)
-0.64%+9.43%-29.91%-37.30% 81.09M
-2.06%-0.33%+20.31%+52.52% 253B
-1.83%-2.15%+5.85%+18.13% 160B
+1.12%-3.27%-18.23%+57.21% 151B
+5.57%-2.76%-56.00%-15.61% 64.23B
+0.20%+3.70%-11.06%-9.50% 54.11B
+1.36%+2.98%+13.11%+42.32% 53.76B
-1.90%-3.51%+5.43%+61.66% 49.71B
-1.65%-2.26%+17.51%+64.63% 48.49B
-2.85%-1.41%+28.58%+83.18% 44.17B
Average -0.27%+0.45%-2.44%+31.72% 87.93B
Weighted average by Cap. -0.57%-0.75%+2.51%+40.35%

Financials

2026 *2027 *
Net sales 414M 42.27M 37.74M 34.63M 31.51M 59.07M 4B 60.25M 167M 2.11B 159M 155M 6.67B 455M 46.45M 41.47M 38.06M 34.62M 64.91M 4.4B 66.2M 183M 2.32B 174M 171M 7.33B
Net income 56.83M 5.81M 5.19M 4.76M 4.33M 8.12M 550M 8.28M 22.91M 290M 21.8M 21.33M 917M 66.07M 6.75M 6.03M 5.53M 5.03M 9.43M 639M 9.62M 26.63M 337M 25.34M 24.8M 1.07B
Net Debt -158M -16.13M -14.4M -13.22M -12.02M -22.54M -1.53B -22.99M -63.64M -806M -60.55M -59.26M -2.55B -201M -20.57M -18.37M -16.86M -15.33M -28.75M -1.95B -29.32M -81.15M -1.03B -77.21M -75.57M -3.25B
Projected Income Statement - Annual - C-Rad AB
Logo C-Rad AB
C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.
Employees
98
Date Price Change Volume
26-11-03 SEK 23.50 0.00% 15,695
26-11-02 SEK 23.50 +1.29% 52,623
26-10-30 SEK 23.20 0.00% 57,314
26-10-29 SEK 23.20 +7.91% 77,613
26-10-28 SEK 21.50 +1.42% 76,969
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - C-Rad AB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
23.50SEK
Average target price
35.00SEK
Spread / Average Target
+48.94%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - C-Rad AB
  1. Stock Market
  2. Stocks
  3. CRAD B Stock